1. Home
  2. TIL vs EHI Comparison

TIL vs EHI Comparison

Compare TIL & EHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TIL
  • EHI
  • Stock Information
  • Founded
  • TIL 2018
  • EHI 2003
  • Country
  • TIL United States
  • EHI United States
  • Employees
  • TIL N/A
  • EHI N/A
  • Industry
  • TIL Biotechnology: Pharmaceutical Preparations
  • EHI Investment Managers
  • Sector
  • TIL Health Care
  • EHI Finance
  • Exchange
  • TIL Nasdaq
  • EHI Nasdaq
  • Market Cap
  • TIL 177.1M
  • EHI 192.4M
  • IPO Year
  • TIL 2021
  • EHI N/A
  • Fundamental
  • Price
  • TIL $12.74
  • EHI $6.39
  • Analyst Decision
  • TIL Strong Buy
  • EHI
  • Analyst Count
  • TIL 5
  • EHI 0
  • Target Price
  • TIL $100.67
  • EHI N/A
  • AVG Volume (30 Days)
  • TIL 62.5K
  • EHI 44.5K
  • Earning Date
  • TIL 11-13-2025
  • EHI 01-01-0001
  • Dividend Yield
  • TIL N/A
  • EHI 11.54%
  • EPS Growth
  • TIL N/A
  • EHI N/A
  • EPS
  • TIL N/A
  • EHI N/A
  • Revenue
  • TIL N/A
  • EHI N/A
  • Revenue This Year
  • TIL N/A
  • EHI N/A
  • Revenue Next Year
  • TIL N/A
  • EHI N/A
  • P/E Ratio
  • TIL N/A
  • EHI N/A
  • Revenue Growth
  • TIL N/A
  • EHI N/A
  • 52 Week Low
  • TIL $10.80
  • EHI $6.00
  • 52 Week High
  • TIL $42.79
  • EHI $7.75
  • Technical
  • Relative Strength Index (RSI)
  • TIL 31.33
  • EHI 50.09
  • Support Level
  • TIL $13.53
  • EHI $6.33
  • Resistance Level
  • TIL $16.00
  • EHI $6.40
  • Average True Range (ATR)
  • TIL 1.32
  • EHI 0.05
  • MACD
  • TIL -0.22
  • EHI 0.01
  • Stochastic Oscillator
  • TIL 7.95
  • EHI 68.00

About TIL Instil Bio Inc.

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.

About EHI Western Asset Global High Income Fund Inc

Western Asset Global High Inc Fd Inc is a non-diversified, closed-end management investment company. Its investment objective is high current income and total return by investing in a world-wide portfolio of securities. The fund invests in various sectors such as Consumer Discretionary, Financials, Energy, Communication energy, Industrials, materials, and others.

Share on Social Networks: